The city of Parsippany, New Jersey.  The 31st of December. Ascensia Diabetes Care, a global diabetes care company, announces its participation in a new film series that tells the story of patient advocate Troy Ita, who uses Eversense® as part of his diabetes treatment program.. Presented by MedTech Europe and including a film produced for the organization by BBC StoryWorks Commercial Productions, a branded content studio at BBC Studios, the 'Connecting the Dots' series takes a look at the history of medical technology as it evolves, celebrating both cutting-edge innovations and enduring healthcare solutions that empower people.. There is a series available on the website at the following link:.medtechconnectingthedots.Com (www.com)
Com (www.com)
A series of short films has been selected by MedTech Europe to examine innovations in medical technology that are helping to shape the future of healthcare and guide a path towards a healthier future for the global population through this series of short films. Among the twenty films that make up the series, Ascensia's mini-documentary style video highlights Troy's journey due to diabetes, and how the evolution of continuous glucose monitoring technology (CGM) has enabled him to live a more full, less interrupted life since being diagnosed with diabetes. It illustrates, in particular, the transformation that Eversense, the only long-term continuous glucose monitoring system available today, can bring to people with diabetes, as seen through the eyes of Troy and his endocrinologist, Dr.. I am Rakesh Patel, an Information Technology professional.*
*
The series is a collection of short films that have been selected by MedTech Europe to showcase innovations in medical technology that are guiding the path towards a healthier future for the global population by exploring innovations in medical technology. Ascensia's mini-documentary style video, which is one of twenty that will be included in the series, tells the story of Troy's journey with diabetes and how continuous glucose monitoring (CGM) technology has helped him to lead a fuller, less interrupted life due to the advancement of CGM technology. As a result, the film provides insight into the transformation that Eversense, one of the few long-term CGM systems available, can bring to people with diabetes through the lens of Troy and his endocrinologist Dr.. The following is a transcript of Rakesh Patel's speech
The following is a transcript of Rakesh Patel's speech
According to Dr. Rakesh Patel, in the film series, we used a regular glucometer when Troy first came in to be treated, before moving onto a continuous glucose monitoring system for a short period of time. He had some grievances with the short-term sensors – mainly because they tend to fall off regularly and there is the burden of replacing them every 10 to 14 days."
During the film, Troy said, "I was constantly on the road for my job, so managing my diabetes has become a juggling act. When the long-term continuous glucose monitor was introduced, it was a game changer for me because I was constantly on the road.".
It is a great pleasure for us to offer people with diabetes the benefits of long-term CGM systems, and we are always humbled by the impact it has on people's lives," said Elaine Anderson, vice president of global CGM and commercial operations for Ascensia Diabetes Care. In our opinion, there is a lot to be excited about in the world of medical technology right now, and we would like to thank MedTech Europe for bringing so many interesting perspectives to the forefront of this film series.
The Eversense E3 CGM System, designed by Senseonics and brought to patients by Ascensia, is the latest generation of continuous glucose monitoring with a sensor wear duration of up to six months.. A potential Eversense E3 user can visit the Eversense website at www.eversense.com.The Eversensecgm.Visit our website at www.com for more information. For physicians, nurse practitioners, and physician assistants who are interested in offering the Eversense E3 CGM System to their patients, they can sign up at www.eversense.com.In a nutshell.Visit http://bit.ly/eversense-becomes-a-provider/. In addition, you can contact 1-844-SENSE4U (1-844-736-7348) if you would like to learn more about the first and only long-term implantable CGM system available. Check out the following website for important safety information:.Acute diabetic retinopathy.Click here: www.eversense.com/safety-info
Click here: www.eversense.com/safety-info
PHC Holdings Corporation (TSE: 6523), a company listed on the Toronto Stock Exchange, owns and operates Ascensia Diabetes Care, the maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio, as well as the exclusive distributor of the Eversense® Continuous Glucose Monitoring (CGM) System portfolio.
It is important to note that this is an offer for U.S. residents only. Troy and Dr. Patel were paid for their participation in this video.
This photo can be found at https://mma.prnewswire.com/media/2293041/Ascensia_Diabetes_Care.jpg and this logo can be found at https://mma.prnewswire.com/media/749389/Ascensia_Diabetes_Care_Logo.jpg.
Ascensia Diabetes Care is the source of this information
Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on developing innovative...
Ascensia Diabetes Care, a global diabetes care company, is the exclusive owner of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and is focused on providing...
Get PRN's top stories and curated news delivered to your inbox each week when you sign up!

Source prnewswire